Solitary pancreas transplantation: Experience with 62 consecutive cases

Robert J. Stratta, Lamont G. Weide, Rakesh Sindhi, Debra Sudan, John T. Jerius, Jennifer Lynn Larsen, Kathleen Cushing, Martin T. Grune, Stanley J Radio

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

OBJECTIVE - To determine the safety and efficacy of solitary pancreas transplantation in the treatment of IDDM. RESEARCH DESIGN AND METHODS - A single-center retrospective case series of 62 consecutive solitary pancreas transplants (20 sequential pancreas after kidney, 42 pancreas transplants alone) performed in 57 adult IDDM patients was studied. Indications for solitary pancreas transplantation were 1) the presence of two or more overt diabetic complications and/or 2) glucose hyperlability with hypoglycemic unawareness and impaired quality of life. The recipient group consisted of 31 men and 26 women with a mean age of 38 years (range 25-62) and a mean duration of diabetes of 26 years (range 14-52). Mean pretransplant glycohemoglobin level was 9.9 ± 2.6%. Organ acceptance was restricted to ideal donors and mandated a minimum of a two-antigen match (mean human leukocyte antigen ABDR match 2.7). The mean cold ischemia was 16.6 h. Whole- organ pancreas transplantation was performed with bladder drainage by the duodenal segment technique. All patients were managed with either triple or quadruple immunosuppression. Monitoring included prospective urine cytology as well as cystoscopic transduodenal needle biopsies. RESULTS - The mean length of initial hospital stay was 18 days, and mean hospital charges were $106,341. The incidences of rejection, infection, and surgical complications were 70, 55, and 47%, respectively. Overall patient and graft survival rates were 86 and 52%, respectively, with a mean follow-up of 28 months. All patients with functioning grafts had excellent metabolic control (mean glycohemoglobin level 5.1%) and achieved good rehabilitation. CONCLUSIONS - Despite morbidity, solitary pancreas transplantation can be performed with improving success, can enhance quality of life, and can offer an opportunity to arrest secondary diabetic complications.

Original languageEnglish (US)
Pages (from-to)362-368
Number of pages7
JournalDiabetes Care
Volume20
Issue number3
DOIs
StatePublished - Mar 1997

Fingerprint

Pancreas Transplantation
Pancreas
Diabetes Complications
Transplants
Type 1 Diabetes Mellitus
Quality of Life
Hospital Charges
Cold Ischemia
Needle Biopsy
Organ Transplantation
Graft Survival
HLA Antigens
Hypoglycemic Agents
Immunosuppression
Cell Biology
Drainage
Length of Stay
Urinary Bladder
Research Design
Rehabilitation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Solitary pancreas transplantation : Experience with 62 consecutive cases. / Stratta, Robert J.; Weide, Lamont G.; Sindhi, Rakesh; Sudan, Debra; Jerius, John T.; Larsen, Jennifer Lynn; Cushing, Kathleen; Grune, Martin T.; Radio, Stanley J.

In: Diabetes Care, Vol. 20, No. 3, 03.1997, p. 362-368.

Research output: Contribution to journalArticle

Stratta, RJ, Weide, LG, Sindhi, R, Sudan, D, Jerius, JT, Larsen, JL, Cushing, K, Grune, MT & Radio, SJ 1997, 'Solitary pancreas transplantation: Experience with 62 consecutive cases', Diabetes Care, vol. 20, no. 3, pp. 362-368. https://doi.org/10.2337/diacare.20.3.362
Stratta, Robert J. ; Weide, Lamont G. ; Sindhi, Rakesh ; Sudan, Debra ; Jerius, John T. ; Larsen, Jennifer Lynn ; Cushing, Kathleen ; Grune, Martin T. ; Radio, Stanley J. / Solitary pancreas transplantation : Experience with 62 consecutive cases. In: Diabetes Care. 1997 ; Vol. 20, No. 3. pp. 362-368.
@article{7ac61562e51841ee8e4472138ac252bd,
title = "Solitary pancreas transplantation: Experience with 62 consecutive cases",
abstract = "OBJECTIVE - To determine the safety and efficacy of solitary pancreas transplantation in the treatment of IDDM. RESEARCH DESIGN AND METHODS - A single-center retrospective case series of 62 consecutive solitary pancreas transplants (20 sequential pancreas after kidney, 42 pancreas transplants alone) performed in 57 adult IDDM patients was studied. Indications for solitary pancreas transplantation were 1) the presence of two or more overt diabetic complications and/or 2) glucose hyperlability with hypoglycemic unawareness and impaired quality of life. The recipient group consisted of 31 men and 26 women with a mean age of 38 years (range 25-62) and a mean duration of diabetes of 26 years (range 14-52). Mean pretransplant glycohemoglobin level was 9.9 ± 2.6{\%}. Organ acceptance was restricted to ideal donors and mandated a minimum of a two-antigen match (mean human leukocyte antigen ABDR match 2.7). The mean cold ischemia was 16.6 h. Whole- organ pancreas transplantation was performed with bladder drainage by the duodenal segment technique. All patients were managed with either triple or quadruple immunosuppression. Monitoring included prospective urine cytology as well as cystoscopic transduodenal needle biopsies. RESULTS - The mean length of initial hospital stay was 18 days, and mean hospital charges were $106,341. The incidences of rejection, infection, and surgical complications were 70, 55, and 47{\%}, respectively. Overall patient and graft survival rates were 86 and 52{\%}, respectively, with a mean follow-up of 28 months. All patients with functioning grafts had excellent metabolic control (mean glycohemoglobin level 5.1{\%}) and achieved good rehabilitation. CONCLUSIONS - Despite morbidity, solitary pancreas transplantation can be performed with improving success, can enhance quality of life, and can offer an opportunity to arrest secondary diabetic complications.",
author = "Stratta, {Robert J.} and Weide, {Lamont G.} and Rakesh Sindhi and Debra Sudan and Jerius, {John T.} and Larsen, {Jennifer Lynn} and Kathleen Cushing and Grune, {Martin T.} and Radio, {Stanley J}",
year = "1997",
month = "3",
doi = "10.2337/diacare.20.3.362",
language = "English (US)",
volume = "20",
pages = "362--368",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Solitary pancreas transplantation

T2 - Experience with 62 consecutive cases

AU - Stratta, Robert J.

AU - Weide, Lamont G.

AU - Sindhi, Rakesh

AU - Sudan, Debra

AU - Jerius, John T.

AU - Larsen, Jennifer Lynn

AU - Cushing, Kathleen

AU - Grune, Martin T.

AU - Radio, Stanley J

PY - 1997/3

Y1 - 1997/3

N2 - OBJECTIVE - To determine the safety and efficacy of solitary pancreas transplantation in the treatment of IDDM. RESEARCH DESIGN AND METHODS - A single-center retrospective case series of 62 consecutive solitary pancreas transplants (20 sequential pancreas after kidney, 42 pancreas transplants alone) performed in 57 adult IDDM patients was studied. Indications for solitary pancreas transplantation were 1) the presence of two or more overt diabetic complications and/or 2) glucose hyperlability with hypoglycemic unawareness and impaired quality of life. The recipient group consisted of 31 men and 26 women with a mean age of 38 years (range 25-62) and a mean duration of diabetes of 26 years (range 14-52). Mean pretransplant glycohemoglobin level was 9.9 ± 2.6%. Organ acceptance was restricted to ideal donors and mandated a minimum of a two-antigen match (mean human leukocyte antigen ABDR match 2.7). The mean cold ischemia was 16.6 h. Whole- organ pancreas transplantation was performed with bladder drainage by the duodenal segment technique. All patients were managed with either triple or quadruple immunosuppression. Monitoring included prospective urine cytology as well as cystoscopic transduodenal needle biopsies. RESULTS - The mean length of initial hospital stay was 18 days, and mean hospital charges were $106,341. The incidences of rejection, infection, and surgical complications were 70, 55, and 47%, respectively. Overall patient and graft survival rates were 86 and 52%, respectively, with a mean follow-up of 28 months. All patients with functioning grafts had excellent metabolic control (mean glycohemoglobin level 5.1%) and achieved good rehabilitation. CONCLUSIONS - Despite morbidity, solitary pancreas transplantation can be performed with improving success, can enhance quality of life, and can offer an opportunity to arrest secondary diabetic complications.

AB - OBJECTIVE - To determine the safety and efficacy of solitary pancreas transplantation in the treatment of IDDM. RESEARCH DESIGN AND METHODS - A single-center retrospective case series of 62 consecutive solitary pancreas transplants (20 sequential pancreas after kidney, 42 pancreas transplants alone) performed in 57 adult IDDM patients was studied. Indications for solitary pancreas transplantation were 1) the presence of two or more overt diabetic complications and/or 2) glucose hyperlability with hypoglycemic unawareness and impaired quality of life. The recipient group consisted of 31 men and 26 women with a mean age of 38 years (range 25-62) and a mean duration of diabetes of 26 years (range 14-52). Mean pretransplant glycohemoglobin level was 9.9 ± 2.6%. Organ acceptance was restricted to ideal donors and mandated a minimum of a two-antigen match (mean human leukocyte antigen ABDR match 2.7). The mean cold ischemia was 16.6 h. Whole- organ pancreas transplantation was performed with bladder drainage by the duodenal segment technique. All patients were managed with either triple or quadruple immunosuppression. Monitoring included prospective urine cytology as well as cystoscopic transduodenal needle biopsies. RESULTS - The mean length of initial hospital stay was 18 days, and mean hospital charges were $106,341. The incidences of rejection, infection, and surgical complications were 70, 55, and 47%, respectively. Overall patient and graft survival rates were 86 and 52%, respectively, with a mean follow-up of 28 months. All patients with functioning grafts had excellent metabolic control (mean glycohemoglobin level 5.1%) and achieved good rehabilitation. CONCLUSIONS - Despite morbidity, solitary pancreas transplantation can be performed with improving success, can enhance quality of life, and can offer an opportunity to arrest secondary diabetic complications.

UR - http://www.scopus.com/inward/record.url?scp=0031038180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031038180&partnerID=8YFLogxK

U2 - 10.2337/diacare.20.3.362

DO - 10.2337/diacare.20.3.362

M3 - Article

C2 - 9051388

AN - SCOPUS:0031038180

VL - 20

SP - 362

EP - 368

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 3

ER -